Bortezomib
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003
Approved
Approval ID
3f02670b-5683-780c-9d38-5d8f0ef43a14
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 23, 2024
Manufacturers
FDA
NorthStar RxLLC
DUNS: 830546433
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Bortezomib
PRODUCT DETAILS
NDC Product Code72603-270
Application NumberANDA202963
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateJuly 23, 2024
Generic NameBortezomib
INGREDIENTS (2)
BortezomibActive
Quantity: 3.5 mg in 1 1
Code: 69G8BD63PP
Classification: ACTIB
mannitolInactive
Code: 3OWL53L36A
Classification: IACT